- Home
- BEN vs ELAN Comparison
BEN vs ELAN Comparison
Compare BEN & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEN | ELAN |
|---|---|---|
| Founded | 1947 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 12.7B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BEN | ELAN |
|---|---|---|
| Price | $27.33 | $23.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $25.89 | ★ $27.89 |
| AVG Volume (30 Days) | ★ 4.5M | 4.3M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.84% | N/A |
| EPS Growth | ★ 7.06 | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $5,774,500,000.00 | $4,715,000,000.00 |
| Revenue This Year | N/A | $8.21 |
| Revenue Next Year | $6.07 | $5.31 |
| P/E Ratio | $59.18 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $17.62 | $8.59 |
| 52 Week High | $28.32 | $27.72 |
Technical Indicators
Market Signals| Indicator | BEN | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 70.79 | 49.59 |
| Support Level | $26.73 | $22.17 |
| Resistance Level | $28.09 | $25.65 |
| Average True Range (ATR) | 0.69 | 0.89 |
| MACD | 0.46 | 0.05 |
| Stochastic Oscillator | 98.77 | 67.86 |
Price Performance
Historical ComparisonAbout BEN Franklin Resources Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.